Mobile-health Network Solutions Class A Ordinary Shares (MNDR)
$0.9114▼ −5.47%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$0.91▼ 92.41% in range
Nov 5, 2025Low $0.85 · High $28.50Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026
Mobile-health Network Solutions closed at $0.91 on Nov 5, down 5.47%, 96.8% below its 52-week closing high. Volume of 115.5K shares was 0.01× its 20-day average (below normal).
Split-adjusted performance: -40.0% over one month, -87.0% over six months, -93.0% over one year.
Short interest was 26.8K shares at the Oct 15 settlement, down 34.3% from the prior report (3.2% of float, 1.0 days to cover).
Mobile-health Network Solutions is a telehealth solutions provider in Singapore, ranked among the fastest-growing providers according to Frost & Sullivan, based on patient consultations per day and mobile application ranking. It provides services through its MaNaDr platform, accessible via mobile application and website, offering personalized and reliable medical attention to users and enabling healthcare providers to reach more users through virtual clinics without start-up costs, with access to peer-to-peer support groups and partners.
What is MNDR's market cap?
$1.26M, based on the Nov 5 close of $0.91.
Does Mobile-health Network Solutions pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MNDR is sold short?
26.8K shares, 3.2% of float, as of Oct 15, 2026.
About Mobile-health Network Solutions
Mobile-health Network Solutions is a telehealth solutions provider in Singapore, ranked among the fastest-growing providers according to Frost & Sullivan, based on patient consultations per day and mobile application ranking. It provides services through its MaNaDr platform, accessible via mobile application and website, offering personalized and reliable medical attention to users and enabling healthcare providers to reach more users through virtual clinics without start-up costs, with access to peer-to-peer support groups and partners. Its segments are Telemedicine and Other Services, which generate maximum revenue, and Sale of Medicine and Medical Devices. The company generates maximum revenue from Singapore.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology